Gastrointestinal Disease News and Research

RSS

Digestive Health Outcomes Registry for patients with GI disease

The American Gastroenterological Association (AGA), the leading association representing clinicians and researchers who specialize in the digestive tract, and MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today the collaborative initiative to develop a set of registries to assist physicians, payors, policy makers, and other healthcare stakeholders in the study and improvement of clinical and quality outcomes, care management, and cost effectiveness of care delivered to Americans with gastrointestinal disease.

9 Oct 2009

New center for gastrointestinal cancer research established

Georgetown University Medical Center today announced the creation of a center that may help advance a cure for one of the deadliest forms of cancer. The Otto J. Ruesch Center for the Cure of Gastrointestinal (GI) Cancers will fund gastrointestinal cancer research, drug discovery and patient advocacy efforts at the Georgetown Lombardi Comprehensive Cancer Center.

30 Sep 2009

New understanding on how probiotics can prevent disease

Using probiotics successfully against a number of animal diseases has helped scientists from University College Cork, Ireland to understand some of the ways in which they work, which could lead to them using probiotics to prevent and even to treat human diseases.

1 Apr 2009

New vaccine developed for preventing human adenovirus type-3d virus

Common colds typically cause a week of sneezing, aches and pains and then fade away leaving only a sore nose and a few used sick days behind.

2 Feb 2009

Chimerix completes phase I study and starts phase II multi-dose trial for CMX001

Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, has announced that the Company has completed a single and multi-dose Phase I study of CMX001 in healthy volunteers.

6 Jan 2009

FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor

The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.

21 Dec 2008

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

A Centers for Disease Control and Prevention (CDC) study released today claims there is no link between the MMR vaccine and autism. The National Autism Association (NAA) says this study does nothing to dispel the growing public concern over a vaccine-autism connection and raises several questions concerning design and methodology.

4 Sep 2008

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

4 Sep 2008

Quality of care for inflammatory bowel disease patients can be improved

Inflammatory bowel disease (IBD) is a chronic recurrent gastrointestinal disease.

26 Feb 2008

Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease

A new study by researchers at Hasbro Children's Hospital, the pediatric division of Rhode Island Hospital, and Mount Sinai Hospital, New York, offers new insight into the role that the cystic fibrosis gene plays in the development of gastrointestinal disease.

14 Dec 2007

New device rapidly diagnoses gastrointestinal disease by 'reading' the odour of biological fluids

A pioneering new device that could help over four billion adults and children who suffer from infectious diarrhoea in the developing world and reduce outbreaks of diseases such as clostridium difficile (C.Diff) in UK hospital wards is the winner of this year's University of Bristol's New Enterprise Competition.

4 Jul 2007

New smart pill helps diagnose stomach problems

People with the chronic stomach condition known as gastroparesis, or slow stomach emptying, live in fear that eating will cause an episode of nausea, vomiting and abdominal pain.

24 May 2007

Discovery of chemical profiles for infectious diarrhoea

Academics from the Universities of the West of England and Bristol have found that faeces from healthy people and those with infectious diarrhoea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile (C. Diff.).

22 May 2007

New method for rapid diagnosis of intestinal illnesses

Academics have found, for the first time, smells from healthy faeces and people with infectious diarrhoea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile (C. Diff.).

27 Feb 2007

New Yorkers lied to in aftermath of 9/11

A new study released this week says thousands of World Trade Center responders have developed chronic and disabling illnesses that are likely to be permanent.

12 Sep 2006

New oral vaccine against Pseudomonas aeruginosa

A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.

23 Feb 2006

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.

6 Jan 2006

Color doppler sonography speeds detection of necrotizing enterocolitis in premature infants

Measuring blood flow to a newborn's intestines using a special form of ultrasound can help radiologists identify a life-threatening complication in a serious bowel disease, according to a study in the May issue of the journal Radiology.

26 Apr 2005

Adding growth factor to baby formula could reduce necrotizing enterocolitis

Could it be that the most widespread and devastating gastrointestinal disease affecting premature babies could be conquered simply by adding a common polypeptide, epidermal growth factor (EGF), to infant formula? And if so, exactly how does it work, and why?

3 Apr 2005

Genomics tools provide clues to what causes 400 million cases of gastrointestinal disease each year

In a study that could benefit medical and food-safety research, scientists have used comparative genomics tools to find clues about why some strains of the bacterium Campylobacter – which each year cause more than 400 million cases of gastrointestinal disease – are more virulent than others.

4 Jan 2005

Gastrointestinal Disease News and Research

Digestive Health Outcomes Registry for patients with GI disease

New center for gastrointestinal cancer research established

New understanding on how probiotics can prevent disease

New vaccine developed for preventing human adenovirus type-3d virus

Chimerix completes phase I study and starts phase II multi-dose trial for CMX001

FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

Quality of care for inflammatory bowel disease patients can be improved

Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease

New device rapidly diagnoses gastrointestinal disease by 'reading' the odour of biological fluids

New smart pill helps diagnose stomach problems

Discovery of chemical profiles for infectious diarrhoea

New method for rapid diagnosis of intestinal illnesses

New Yorkers lied to in aftermath of 9/11

New oral vaccine against Pseudomonas aeruginosa

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Color doppler sonography speeds detection of necrotizing enterocolitis in premature infants

Adding growth factor to baby formula could reduce necrotizing enterocolitis

Genomics tools provide clues to what causes 400 million cases of gastrointestinal disease each year

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News